The kinetics of the reactions of CT-esterase inhibitor with C i s or C i r has been studied in purified systems. Both reactions were found to proceed in two steps: a fast reversible second-order reaction followed by a slower irreversible first-order transition according to the following scheme: E + I A E I k ' . EI'. The rate constant kl for the reaction between C i s and Ci-esterase inhibitor was found to be 1 . 4~ lo5 M-' s-l at 25"C and 4 . 7~ 105 M -I S -~ at 37 "C, while the corresponding values for the reaction between C i r and Ci-esterase inhibitor were 2.5 x lo3 M-' s-' and 4.4 x lo4 M-' s-', respectively. The dissociation constant K of the initial complex was estimated as 1 -2 n M for the complex with C i s and 20-50 nM for the complex with Cir. Heparin was found to accelerate the rate of the Cfs/Cf-esterase inhibitor reaction by a 16-fold increase in kl at heparin concentrations above 100 mg/l, whereas no effect was obtained on the thermodynamic equilibrium. The inhibition of purified CIS added to dilutions of plasma or serum was found to proceed as expected from their known concentrations of Ci-esterase inhibitor and the rate constants determined in the purified system. Thus, the halflife of C i s in plasma under pseudo-first-order kinetics would be about 1 s
A tThe classical pathway of the complement system is initially activated by limited proteolysis of the complement components by C l r and Cfs. These enzymes occur in plasma as single-chain zymogens in the so-called C1 complex [l]. Upon activation, C l r and C I S are cleaved to yield the active enzymes consisting of two disulphide-bonded polypeptide chains. The main inhibitor of these enzymes in human plasma is the CTesterase inhibitor [2]. During the reaction of CT-esterase inhibitor with CTr or Cis very stable stoichiometric 1 : 1 inactive complexes are formed involving the light chain of the enzymes [3].Recently an attempt to investigate the kinetics of these reactions in a purified system was performed [4]. It was suggested that the reactions were composed of two steps, the first of which was reversible and the second of which was irreversible. However, only the overall reaction was studied and n o experimental data was presented to supported the proposed mechanism. In the present investigation we have performed a mechanistic evaluation of the interaction between Ci-esterase inhibitor and C i s or C l r and determined the kinetic constants in purified systems as well as in plasma and serum.
MATERIALS A N D METHODS
C~-E s t t v m e InhibitorCi-esterase inhibitor was purified from freshly frozen human citrated plasma by poly(ethy1ene glycol) precipitation, DEAE-cellulose chromatography, and hydrophobic interaction chromatography on hexyl-Sepharose, as previously described [5]. The final product is a homogeneous protein which, when incubated with a molar excess of C i s (25"C, loinin), quantitatively forms a complex with the enzyme, as demon- strated by dodecylsulfate/polyacrylamide gel electrophoresis. The concentration was determined from the...